Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.

作者: I. Balgkouranidou , D. Matthaios , A. Karayiannakis , H. Bolanaki , P. Michailidis

DOI: 10.1016/J.MRFMMM.2015.05.002

关键词:

摘要: Gastric carcinogenesis is a multistep process including not only genetic mutations but also epigenetic alterations. The best known and more frequent alteration DNA methylation affecting tumor suppressor genes that may be involved in various carcinogenetic pathways. aim of the present study was to investigate status APC promoter 1A RASSF1A cell free operable gastric cancer patients. Using specific PCR, we examined 73 blood samples obtained from patients with cancer. APC promoters were found methylated 61 (83.6%) 50 (68.5%) examined, none healthy control (p < 0.001). A significant association between lymph node positivity observed = 0.005). Additionally, correlation elevated CEA 0.033) as well CA-19.9 0.032) levels, noticed. Kaplan–Meier estimates survival, significantly favored non-methylated 0.008). No other correlations different variables observed. Serum hypermethylation event early cancer. survival hypermethylated nodal indicative prognostic role for those Additional studies, larger cohort are required further explore whether these findings could serve potential molecular biomarkers and/or response treatments.

参考文章(35)
Demao Yao, Nongyue He, Bingyin Shi, Meiju Ji, Jing Shi, Na Wang, Guanjun Zhang, Wei Liu, Peng Hou, Prognostic significance of aberrant gene methylation in gastric cancer. American Journal of Cancer Research. ,vol. 2, pp. 116- 129 ,(2012)
Manel Esteller, Cancer Epigenetics: Dna Methylation and Chromatin Alterations in Human Cancer Advances in Experimental Medicine and Biology. ,vol. 532, pp. 39- 49 ,(2003) , 10.1007/978-1-4615-0081-0_5
Zhen-Kai Wang, Jiong Liu, Chan Liu, Fang-Yu Wang, Chun-Yan Chen, Xin-Hua Zhang, Hypermethylation of adenomatous polyposis coli gene promoter is associated with novel Wnt signaling pathway in gastric adenomas. Journal of Gastroenterology and Hepatology. ,vol. 27, pp. 1629- 1634 ,(2012) , 10.1111/J.1440-1746.2012.07219.X
Sung-Gil Chi, Byung-Gyu Ryu, Kwon-Seok Chae, Do-Sun Byun, Min-Goo Lee, Frequent Epigenetic Inactivation of RASSF1A by Aberrant Promoter Hypermethylation in Human Gastric Adenocarcinoma Cancer Research. ,vol. 61, pp. 7034- 7038 ,(2001)
Sing-Huang Tan, Hiroshi Ida, Quek-Choon Lau, Boon-Cher Goh, Wei-Shieng Chieng, Marie Loh, Yoshiaki Ito, Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3. Oncology Reports. ,vol. 18, pp. 1225- 1230 ,(2007) , 10.3892/OR.18.5.1225
Jacques Ferlay, Hai-Rim Shin, Freddie Bray, David Forman, Colin Mathers, Donald Maxwell Parkin, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. ,vol. 127, pp. 2893- 2917 ,(2010) , 10.1002/IJC.25516
Haya Abu Ghazaleh, Renfred S. Chow, Sheryl L. Choo, Diana Pham, Jamie D. Olesen, Russell X. Wong, Christina Onyskiw, Shairaz Baksh, 14-3-3 mediated regulation of the tumor suppressor protein, RASSF1A. Apoptosis. ,vol. 15, pp. 117- 127 ,(2010) , 10.1007/S10495-009-0451-6
Stephen B Baylin, DNA methylation and gene silencing in cancer Nature Reviews Clinical Oncology. ,vol. 2, ,(2005) , 10.1038/NCPONC0354
Takeshi Nakajima, Shotaro Enomoto, Toshikazu Ushijima, DNA methylation: a marker for carcinogen exposure and cancer risk Environmental Health and Preventive Medicine. ,vol. 13, pp. 8- 15 ,(2008) , 10.1007/S12199-007-0005-X